HHTG(SH:600095)2017-04-28 16:00Financial Performance - Operating revenue fell by 32.52% to CNY 35,860,207.48 year-on-year[6] - Net profit attributable to shareholders was a loss of CNY 8,333,538.65, compared to a loss of CNY 2,428,023.49 in the same period last year[6] - Basic and diluted earnings per share were both -0.0217 CNY, compared to -0.0067 CNY in the same period last year[6] - Total operating revenue for Q1 2017 was ¥35,860,207.48, a decrease of 32.5% compared to ¥53,140,905.09 in the same period last year[20] - Net profit for Q1 2017 was -¥9,284,402.81, compared to -¥3,582,621.82 in Q1 2016, representing a 158.5% increase in losses[20] - The company recorded a total comprehensive loss of -¥9,246,602.81 for Q1 2017, compared to -¥6,220,221.82 in Q1 2016, indicating a 48.7% increase in comprehensive losses[20] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 9,620,613.74, contrasting with a net inflow of CNY 2,708,631.20 in the previous year[6] - Cash received from operating activities decreased to ¥32,552,208.49, down 48.0% from ¥62,690,373.70 in the previous year[23] - The net cash flow from operating activities for Q1 2017 was -37,359,109.59 RMB, compared to -7,867,352.15 RMB in the previous period, indicating a significant decline in operational performance[26] - The total cash outflow for operating activities was 55,542,699.42 RMB, compared to 134,443,758.61 RMB in the previous period, showing a reduction in operational cash outflows[26] - The company experienced a net decrease in cash and cash equivalents of -77,201,328.27 RMB during the quarter, compared to a smaller decrease of -6,817,127.10 RMB in the previous period[26] Assets and Liabilities - Total assets decreased by 2.10% to CNY 1,095,921,800.73 compared to the end of the previous year[6] - Current assets totaled CNY 701,110,204.30, a decrease from CNY 756,191,832.75 at the beginning of the year[15] - Total liabilities decreased from CNY 464,621,171.29 to CNY 450,985,756.82, a reduction of approximately 2.8%[18] - Total equity decreased from CNY 604,597,212.04 to CNY 599,539,033.44, a reduction of approximately 0.9%[18] - Cash and cash equivalents decreased from CNY 215,694,573.67 to CNY 138,493,245.40, a decline of about 35.9%[17] Expenses - Operating costs decreased by 30.39% to CNY 21,147,327.91 from CNY 30,380,756.52 year-on-year[11] - Sales expenses fell by 36.76% to CNY 2,042,114.47 compared to CNY 3,229,343.92 in the previous year[11] - Financial expenses increased by 92.59% to CNY 2,683,065.88 due to a higher balance of bank loans compared to the same period last year[11] - The company incurred financial expenses of ¥2,683,065.88 in Q1 2017, which is a 92.7% increase from ¥1,393,176.34 in the same period last year[20] Shareholder Information - The number of shareholders totaled 34,306 at the end of the reporting period[8] - The largest shareholder, Zhejiang Xinhuhua Group Co., Ltd., held 16.08% of the shares, totaling 58,094,308 shares[8] Government Support and Other Income - The company received government subsidies amounting to CNY 58,679.07, which are closely related to its normal business operations[9] - The company reported a fair value change gain of CNY 458,630.14 from trading financial assets and liabilities[9] - Other comprehensive income after tax for Q1 2017 was ¥37,800.00, compared to -¥2,637,600.00 in the same period last year, showing a significant recovery[21] Investment and Capital Expenditures - The company reported a significant decrease in the construction in progress, primarily due to renovations at Harbin High-tech White Swan Pharmaceutical Group Co., Ltd.[10] - The total cash outflow from investing activities was 36,134,774.28 RMB, significantly higher than the previous period's outflow of 12,200,000.00 RMB, indicating increased investment expenditures[26]